01 1DARMERICA, LLC
02 1Hangzhou Sinodo Pharm Technology Co.,Ltd
03 1Qingdao Biopeptek Co., Ltd.
01 1Dihexa
02 1Dihexa Aceate
03 1Dihexa Acetate
01 2U.S.A
02 1Blank
NDC Package Code : 73212-034
Start Marketing Date : 2022-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-545
Start Marketing Date : 2019-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82907-349
Start Marketing Date : 2023-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (30g/30g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Dihexa manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihexa, including repackagers and relabelers. The FDA regulates Dihexa manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihexa API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihexa manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihexa supplier is an individual or a company that provides Dihexa active pharmaceutical ingredient (API) or Dihexa finished formulations upon request. The Dihexa suppliers may include Dihexa API manufacturers, exporters, distributors and traders.
click here to find a list of Dihexa suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dihexa as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dihexa API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dihexa as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dihexa and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dihexa NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dihexa suppliers with NDC on PharmaCompass.
We have 2 companies offering Dihexa
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
